Josh Friedman

2 weeks ago | healio.com | Josh Friedman |Heather Biele

Key takeaways: Many news stories that report on public figures with cancer do not specify cancer type. Stories often do not include details about cancer stage, prognosis or treatments. In 2024, both Kate Middleton, Princess of Wales, and King Charles III told the world they had cancer. After each announcement, David J. Benjamin, MD, oncologist at Hoag Family Cancer Institute in California, had patients asking him the same questions: What do you think this individual’s cancer is?

2 weeks ago | healio.com | Josh Friedman

Key takeaways:Academic medical oncologists need protected time to conduct clinical trials and research. Academic medical centers could lose their oncologists to industry if changes are not made. Eric P. Winer, MD, FASCO, cannot think of a better time to be a medical oncologist. There are more therapies than ever, and those treatments are highly effective. Patients with cancer are living longer, while experiencing fewer adverse events.

2 weeks ago | healio.com | Josh Friedman

Key takeaways:An Australian man stayed cancer free for 22 months after receiving an experimental neoadjuvant immunotherapy regimen for glioblastoma. An international trial will start enrolling patients later this year. An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel immunotherapy regimen for glioblastoma developed based on his own studies.

3 weeks ago | healio.com | Josh Friedman |Heather Biele

Key takeaways: Smoking cessation and reduction prevented more than 3.8 million lung cancer deaths between 1970 and 2022. Smoking declines added approximately 20 years of life for every individual who did not die of lung cancer. Cigarette smoking declines over the past several decades prevented an estimated 3.8 million lung cancer deaths, according to results of a retrospective study.

3 weeks ago | healio.com | Josh Friedman |Heather Biele |Allison W. Kurian |Ann H. Partridge

Key takeaways: Most women with breast cancer who paused endocrine therapy for pregnancy did not resume. These women had a higher rate of breast recurrence and death than expected. Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, according to results of a nearly 25-year retrospective study.